Dietary Compound Isoliquiritigenin Inhibits Breast Cancer Neoangiogenesis via VEGF/VEGFR-2 Signaling Pathway
出版年份 2013 全文链接
标题
Dietary Compound Isoliquiritigenin Inhibits Breast Cancer Neoangiogenesis via VEGF/VEGFR-2 Signaling Pathway
作者
关键词
Endothelial cells, Angiogenesis, Breast cancer, Cancer treatment, Proteasomes, Enzyme-linked immunoassays, VEGF signaling, Signal inhibition
出版物
PLoS One
Volume 8, Issue 7, Pages e68566
出版商
Public Library of Science (PLoS)
发表日期
2013-07-06
DOI
10.1371/journal.pone.0068566
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Angiogenesis as a therapeutic target in cancer
- (2013) G. Kumaran et al. CLINICAL MEDICINE
- Ellagic acid, a phenolic compound, exerts anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer
- (2012) Neng Wang et al. BREAST CANCER RESEARCH AND TREATMENT
- Emerging Glycolysis Targeting and Drug Discovery from Chinese Medicine in Cancer Therapy
- (2012) Zhiyu Wang et al. Evidence-based Complementary and Alternative Medicine
- Isoliquiritigenin from licorice root suppressed neovascularisation in experimental ocular angiogenesis models
- (2011) V. Jhanji et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Design, synthesis, and evaluation of 5-methyl-4-phenoxy-5H-pyrrolo[3,2-d]pyrimidine derivatives: Novel VEGFR2 kinase inhibitors binding to inactive kinase conformation
- (2010) Yuya Oguro et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Cancer Chemopreventive Activity and Metabolism of Isoliquiritigenin, a Compound Found in Licorice
- (2010) M. Cuendet et al. Cancer Prevention Research
- Differential Effects of VEGFR-1 and VEGFR-2 Inhibition on Tumor Metastases Based on Host Organ Environment
- (2010) Y.-J. Lee et al. CANCER RESEARCH
- VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis
- (2010) Luqing Zhang et al. CELL RESEARCH
- Bevacizumab toxicities and their management in ovarian cancer
- (2010) Leslie M. Randall et al. GYNECOLOGIC ONCOLOGY
- Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion
- (2010) Dimitra Bourboulia et al. SEMINARS IN CANCER BIOLOGY
- Tissue factor in cancer progression and angiogenesis
- (2010) Wolfram Ruf et al. THROMBOSIS RESEARCH
- Use of anti-VEGF adjuvant therapy in cancer: challenges and rationale
- (2010) Anil Bagri et al. TRENDS IN MOLECULAR MEDICINE
- VEGF receptor trafficking in angiogenesis: Figure 1
- (2009) Alice Scott et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Isoliquiritigenin induces G2 and M phase arrest by inducing DNA damage and by inhibiting the metaphase/anaphase transition
- (2009) Iha Park et al. CANCER LETTERS
- Induction of Cell Cycle Arrest in Prostate Cancer Cells by the Dietary Compound Isoliquiritigenin
- (2009) Yeo Myeong Lee et al. JOURNAL OF MEDICINAL FOOD
- Licorice isoliquiritigenin dampens angiogenic activity via inhibition of MAPK-responsive signaling pathways leading to induction of matrix metalloproteinases
- (2009) Sang-Wook Kang et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Targeting angiogenesis: progress with anti-VEGF treatment with large molecules
- (2009) Axel Grothey et al. Nature Reviews Clinical Oncology
- AKT Signaling in Regulating Angiogenesis
- (2008) Bing-Hua Jiang et al. CURRENT CANCER DRUG TARGETS
- Isoliquiritigenin induces monocytic differentiation of HL-60 cells
- (2008) Defang Li et al. FREE RADICAL BIOLOGY AND MEDICINE
- Dietary administration of the licorice flavonoid isoliquiritigenin deters the growth of MCF-7 cells overexpressing aromatase
- (2008) Lan Ye et al. INTERNATIONAL JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More